On Wednesday, Following U.S. Stocks were among the “Top Losers“: Darling Ingredients Inc (NYSE:DAR), Enterprise Products Partners L.P (NYSE:EPD), VMware, Inc (NYSE:VMW), ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)
Darling Ingredients Inc (NYSE:DAR)’s shares dwindled -2.60%, and closed at $14.24, hitting new 52-week low of $14.21. The stock volatility for the week is 4.66%, while for the month remained 2.71%. The company holds consensus target price of $20.50.
If we consider EPS growth of the company, then we will notice the following observations:
The company showed 0.14 diluted EPS growth for trailing twelve months. However, YTD EPS growth remained -18.00% and Annual EPS growth for the past 5 years is considered as 6.60%.
The mean recommendation of analysts for this stock is 2.20. (where 1=Buy, 5=Sale).
Darling Ingredients Inc. develops, produces, and sells natural ingredients from edible and inedible bio-nutrients worldwide. It operates in three segments: Feed Ingredients, Food Ingredients, and Fuel Ingredients.
Enterprise Products Partners L.P (NYSE:EPD), declined -2.58%, and closed at $31.38. The stock has price to sale value of 1.27, however, price to book value is 3.30. With recent decline, the year-to-date (YTD) performance reflected a -13.12% decline above last year. During the past month the stocks lose -6.72%, bringing three-month performance to -11.23% and six-month performance to -23.67%. The mean recommendation of analysts for this stock is 1.70. (where 1=Buy, 5=Sale).
Enterprise Products Partners L.P. provides midstream energy services to producers and consumers of natural gas, natural gas liquids (NGLs), crude oil, petrochemicals, and refined products in the United States and internationally.
VMware, Inc (NYSE:VMW), dipped -2.50%, and closed at $81.01. The company holds the market capitalization of 35.53B. For the trailing twelve months, the stock’s return on equity value remains 14.90%, while return on assets value is 7.50%, in response to its return on investment value of 9.50%. Its 20-day moving average declined -3.89%, below 50-day moving average of -0.94%, below 200-day moving average of -9.67% from the latest market price of $81.01. The mean recommendation of analysts for this stock is 2.30.(where 1=Buy, 5=Sale).
VMware, Inc. provides virtualization infrastructure solutions in the United States and internationally. The company’s virtualization infrastructure solutions comprise a suite of products designed to deliver a software-defined data center (SDDC), run on industry-standard desktop computers and servers, and support a range of operating system and application environments, in addition to networking and storage infrastructures.
ACADIA Pharmaceuticals Inc (NASDAQ:ACAD), dropped -2.44%, and closed at $44.76. The stock has the beta value of 2.98, and its volatility for the week is 7.97%, while for the month it is 4.42%. The company has the market capitalization of $4.60B. The company holds the book value per share of 3.18, whereas cash per share is 3.22. Price to book value is estimated to be 14.08, while price to sale value is 44836.09. Analysts mean recommendation for the stock is said to be 1.90 (where 1=Buy, 5=sale).
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The data demonstrated in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
